AlphaFold predicted structure
NPR2 · P20594

Mean pLDDT
83.6/ 100
Confident
1,047 residues
Confidence breakdown
- Very high(≥ 90)44%
- Confident(70–90)43%
- Low(50–70)6%
- Very low(< 50)7%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
natriuretic peptide receptor 2
Annotations refreshed 10 hours ago.
Diagnostic Grade (Green)
DDG2P
BIALLELIC, autosomal or pseudoautosomalFetal anomalies
BIALLELIC, autosomal or pseudoautosomalMonogenic short stature
BIALLELIC, autosomal or pseudoautosomalSkeletal dysplasia
BOTH monoallelic and biallelic, autosomal or pseudoautosomalLimb disorders
BOTH monoallelic and biallelic, autosomal or pseudoautosomalFamilial Meniere Disease
Intellectual disability
BIALLELIC, autosomal or pseudoautosomalOsteogenesis imperfecta
Acromesomelic dysplasia, Maroteaux type
acromesomelic dysplasia 1, Maroteaux type
Tall stature - scoliosis - macrodactyly of the great toes
tall stature-scoliosis-macrodactyly of the great toes syndrome
short stature with nonspecific skeletal abnormalities
achondroplasia
congestive heart failure
familial focal epilepsy with variable foci
hereditary disease
bone disorder
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Atrial natriuretic peptide receptor 2
Receptor for the C-type natriuretic peptide NPPC/CNP hormone. Has guanylate cyclase activity upon binding of its ligand. May play a role in the regulation of skeletal growth
NPR2 · P20594

Mean pLDDT
83.6/ 100
Confident
1,047 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0